Search Results

Displaying Results 1-3 of 3 "'CRVS'"

May 21, 2026, 08:59 ET NEXA Lending Enters Strategic Investment and Phased Acquisition Agreement with Copper Ridge Ventures

technology-enabled operating model, AI-forward approach, and deep experience in rapid joint venture formation will help Tim Owens and his team accelerate CRV's growth and drive operational efficiencies."By investing in proven operators and strengthening its joint venture strategy, NEXA continues to position

More news about: NEXA Lending


Apr 21, 2026, 09:00 ET Acsense Launches Identity Assurance to Deliver Real-Time IAM Configuration Visibility and Audit Readiness

warns that autonomous AI systems are collapsing time-to-exploit from weeks to hours and names Identity and Privilege Abuse as a top agentic-AI threat. CRV's 2026 CISO Survey found that 85.7% of security leaders rank AI Security and Agents among their top three threats, and cite identity for AI agents as

More news about: Acsense


Oct 21, 2025, 08:05 ET The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners

advancing twelve oncology assets across four franchises. Earlier in his career, he served as Chief Medical Officer at Corvus Pharmaceuticals (Nasdaq: CRVS), and held positions of increasing responsibility at Genentech (Nasdaq: DNA), where he notably served as group medical director and global development

More news about: Institute for Follicular Lymphoma Innovation (IFLI)


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.